Anzeige
Meldung des Tages: Gold bei 5.250 USD – Dieser 37-Mio.-€-Goldentwickler sitzt auf einem möglichen $2-Milliarden-Projekt!!

Oramed Pharmaceuticals News

Aktie
WKN:  A1CTNU ISIN:  US68403P2039 US-Symbol:  ORMP Branche:  Biotechnologie Land:  USA
3,48 $
+0,11 $
+3,26%
3,0428 € 19:01:02 Uhr
Depot/Watchlist
Marktkapitalisierung *
102,37 Mio. €
Streubesitz
68,19%
KGV
2,18
Dividende
0,25 $
Dividendenrendite
7,50%
Index-Zuordnung
-

Oramed Pharmaceuticals News

13.01.26 - PR Newswire
Oramed and Lifeward Announce Strategic Transaction
Oramed and Lifeward Announce Strategic Transaction PR Newswire
07.01.26 - PR Newswire
Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments
Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments PR Newswire
17.11.25 - PR Newswire
Oramed Reports Fiscal Third Quarter 2025 Financial Results
Oramed Reports Fiscal Third Quarter 2025 Financial Results PR Newswire
17.11.25 - PR Newswire
ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS
ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS PR Newswire
10.11.25 - inv3st.de
Patientenwohl als Schlüssel zu Rendite: Oramed Pharmaceutials, Roche, BioNxt
Höher, schneller, weiter - nicht nur im Sport kommt es auf ständigen Fortschritt an. Auch in Wirtschaft und Wissenschaft geht es um stete Innovationen und Verbesserungen. Die ...
23.10.25 - PR Newswire
Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives
Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives PR Newswire
28.04.25 - PR Newswire
Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical
Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical PR Newswire

Newssuche

Videos

newspaper
19:20 Uhr -1,36%
Technical Trading: Kurzfristig Gold Long
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »